Cargando…

Noninvasive assessment and quantification of tumour vascularisation using MRI and CT in a tumour model with modifiable angiogenesis – An animal experimental prospective cohort study

BACKGROUND: To investigate vascular-related pathophysiological characteristics of two human lung cancers with modifiable vascularisation using MRI and CT. METHODS: Tumour xenografts with modifiable vascularisation were established in 71 rats (approval by the Animal Care Committee was obtained) by su...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirus, M., Tokalov, S. V., Wolf, G., Heinold, J., Prochnow, V., Abolmaali, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909347/
https://www.ncbi.nlm.nih.gov/pubmed/29708186
http://dx.doi.org/10.1186/s41747-017-0014-5
_version_ 1783315884781076480
author Mirus, M.
Tokalov, S. V.
Wolf, G.
Heinold, J.
Prochnow, V.
Abolmaali, N.
author_facet Mirus, M.
Tokalov, S. V.
Wolf, G.
Heinold, J.
Prochnow, V.
Abolmaali, N.
author_sort Mirus, M.
collection PubMed
description BACKGROUND: To investigate vascular-related pathophysiological characteristics of two human lung cancers with modifiable vascularisation using MRI and CT. METHODS: Tumour xenografts with modifiable vascularisation were established in 71 rats (approval by the Animal Care Committee was obtained) by subcutaneous transplantation of two human non-small-cell lung cancer (NSCLC) cells (A549, H1299) either alone or co-transplanted with vascular growth promoters. The vascularity of the tumours was assessed noninvasively by MRI diffusion-weighted-imaging (DWI), T2-weighted, and time-of-flight (TOF) sequences) as well as contrast-enhanced CT (CE-CT), using clinical scanners. As a reference standard, histological examinations (CD-31, fluorescent beads) were done after explantation. RESULTS: Microvessel density (MVD) was higher in co-transplanted tumours (171 ± 19 number/mm(2)) than in non-co-transplanted tumours (111 ± 11 number/mm(2); p = 0.002). Co-transplanted tumours showed higher growth rates and larger tumour vessels at TOF-MRI as well as larger necrotic areas at CE-CT. In co-transplanted tumours, DWI revealed higher cellularity (lower minimal ADC(diff) 166 ± 15 versus 346 ± 27 mm(2)/s × 10(−6); p < 0.001), highly necrotic areas (higher maximal ADC(diff) 1695 ± 65 versus 1320 ± 59 mm(2)/s × 10(−6); p < 0.001), and better-perfused tumour stroma (higher ADC(perf) 723 ± 36 versus 636 ± 51 mm(2)/s × 10(−6); p = 0.005). Significant correlations were found using qualitative and quantitative parameters: maximal ADC(perf) and MVD (r = 0.326); maximal ADC(diff) and relative necrotic volume on CE-CT (r = 0.551); minimal ADC(diff) and MVD (r = −0.395). CONCLUSIONS: Pathophysiological differences related to vascular supply in two human lung cancer cell lines with modifiable vascularity are quantifiable with clinical imaging techniques. Imaging parameters of vascularisation correlated with the results of histology. DWI was able to characterise both the extent of necrosis and the level of perfusion.
format Online
Article
Text
id pubmed-5909347
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-59093472018-04-24 Noninvasive assessment and quantification of tumour vascularisation using MRI and CT in a tumour model with modifiable angiogenesis – An animal experimental prospective cohort study Mirus, M. Tokalov, S. V. Wolf, G. Heinold, J. Prochnow, V. Abolmaali, N. Eur Radiol Exp Original Article BACKGROUND: To investigate vascular-related pathophysiological characteristics of two human lung cancers with modifiable vascularisation using MRI and CT. METHODS: Tumour xenografts with modifiable vascularisation were established in 71 rats (approval by the Animal Care Committee was obtained) by subcutaneous transplantation of two human non-small-cell lung cancer (NSCLC) cells (A549, H1299) either alone or co-transplanted with vascular growth promoters. The vascularity of the tumours was assessed noninvasively by MRI diffusion-weighted-imaging (DWI), T2-weighted, and time-of-flight (TOF) sequences) as well as contrast-enhanced CT (CE-CT), using clinical scanners. As a reference standard, histological examinations (CD-31, fluorescent beads) were done after explantation. RESULTS: Microvessel density (MVD) was higher in co-transplanted tumours (171 ± 19 number/mm(2)) than in non-co-transplanted tumours (111 ± 11 number/mm(2); p = 0.002). Co-transplanted tumours showed higher growth rates and larger tumour vessels at TOF-MRI as well as larger necrotic areas at CE-CT. In co-transplanted tumours, DWI revealed higher cellularity (lower minimal ADC(diff) 166 ± 15 versus 346 ± 27 mm(2)/s × 10(−6); p < 0.001), highly necrotic areas (higher maximal ADC(diff) 1695 ± 65 versus 1320 ± 59 mm(2)/s × 10(−6); p < 0.001), and better-perfused tumour stroma (higher ADC(perf) 723 ± 36 versus 636 ± 51 mm(2)/s × 10(−6); p = 0.005). Significant correlations were found using qualitative and quantitative parameters: maximal ADC(perf) and MVD (r = 0.326); maximal ADC(diff) and relative necrotic volume on CE-CT (r = 0.551); minimal ADC(diff) and MVD (r = −0.395). CONCLUSIONS: Pathophysiological differences related to vascular supply in two human lung cancer cell lines with modifiable vascularity are quantifiable with clinical imaging techniques. Imaging parameters of vascularisation correlated with the results of histology. DWI was able to characterise both the extent of necrosis and the level of perfusion. Springer International Publishing 2017-10-16 /pmc/articles/PMC5909347/ /pubmed/29708186 http://dx.doi.org/10.1186/s41747-017-0014-5 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Mirus, M.
Tokalov, S. V.
Wolf, G.
Heinold, J.
Prochnow, V.
Abolmaali, N.
Noninvasive assessment and quantification of tumour vascularisation using MRI and CT in a tumour model with modifiable angiogenesis – An animal experimental prospective cohort study
title Noninvasive assessment and quantification of tumour vascularisation using MRI and CT in a tumour model with modifiable angiogenesis – An animal experimental prospective cohort study
title_full Noninvasive assessment and quantification of tumour vascularisation using MRI and CT in a tumour model with modifiable angiogenesis – An animal experimental prospective cohort study
title_fullStr Noninvasive assessment and quantification of tumour vascularisation using MRI and CT in a tumour model with modifiable angiogenesis – An animal experimental prospective cohort study
title_full_unstemmed Noninvasive assessment and quantification of tumour vascularisation using MRI and CT in a tumour model with modifiable angiogenesis – An animal experimental prospective cohort study
title_short Noninvasive assessment and quantification of tumour vascularisation using MRI and CT in a tumour model with modifiable angiogenesis – An animal experimental prospective cohort study
title_sort noninvasive assessment and quantification of tumour vascularisation using mri and ct in a tumour model with modifiable angiogenesis – an animal experimental prospective cohort study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909347/
https://www.ncbi.nlm.nih.gov/pubmed/29708186
http://dx.doi.org/10.1186/s41747-017-0014-5
work_keys_str_mv AT mirusm noninvasiveassessmentandquantificationoftumourvascularisationusingmriandctinatumourmodelwithmodifiableangiogenesisananimalexperimentalprospectivecohortstudy
AT tokalovsv noninvasiveassessmentandquantificationoftumourvascularisationusingmriandctinatumourmodelwithmodifiableangiogenesisananimalexperimentalprospectivecohortstudy
AT wolfg noninvasiveassessmentandquantificationoftumourvascularisationusingmriandctinatumourmodelwithmodifiableangiogenesisananimalexperimentalprospectivecohortstudy
AT heinoldj noninvasiveassessmentandquantificationoftumourvascularisationusingmriandctinatumourmodelwithmodifiableangiogenesisananimalexperimentalprospectivecohortstudy
AT prochnowv noninvasiveassessmentandquantificationoftumourvascularisationusingmriandctinatumourmodelwithmodifiableangiogenesisananimalexperimentalprospectivecohortstudy
AT abolmaalin noninvasiveassessmentandquantificationoftumourvascularisationusingmriandctinatumourmodelwithmodifiableangiogenesisananimalexperimentalprospectivecohortstudy